Akkermansia muciniphila is generally considered safe, and pasteurized Akkermansia has been assessed as safe by EFSA for use in food supplements for adults. Potential risks include mild digestive effects, and some studies associate high levels with certain conditions, though causation is unclear. Long-term data on live supplements is limited, so consult a healthcare professional before use.

Akkermansia muciniphila is used in supplements as a freeze-dried live or pasteurized ingredient in capsules, sachets and powders, often in metabolic health, weight management, GLP-1 supportive and gut-immune products, and in synbiotic blends. SwissMedicare Probiotics supplies Akkermansia muciniphila freeze-dried powder at 1–100 billion CFU/g with a 24-month shelf life when stored at or below 25 °C.

There is no established optimal level of Akkermansia muciniphila, but research commonly reports it makes up roughly 1–4% of the gut bacteria in healthy adults. Lower levels have been associated with obesity and metabolic disorders. Levels vary widely between individuals depending on diet, age, medication and health status, so it is not routinely used as a diagnostic marker.

Akkermansia muciniphila was discovered by Muriel Derrien and colleagues in Willem de Vos's laboratory at Wageningen University in the Netherlands, who isolated it from human feces and described it in 2004. Its name honours microbial ecologist Antoon Akkermans, and "muciniphila" means mucin-loving, reflecting its ability to break down intestinal mucus.

You can increase Akkermansia naturally by eating polyphenol-rich foods like cranberries, grapes, pomegranates and green tea, consuming prebiotic fibres such as inulin from onions, garlic and chicory, and including omega-3 fats. Research also links intermittent fasting or calorie restriction and regular exercise with higher Akkermansia levels. Effects vary between individuals.

Akkermansia muciniphila lives in the intestinal mucus layer, where it feeds on mucin and helps maintain gut barrier integrity. Research associates it with metabolic health, insulin sensitivity, glucose regulation, lipid metabolism and immune modulation, making it a leading next-generation probiotic. SwissMedicare Probiotics supplies Akkermansia muciniphila for nutraceuticals, functional foods and animal nutrition.

People who should not take Akkermansia without medical advice include pregnant or breastfeeding women, children, immunocompromised individuals and people with serious digestive conditions such as inflammatory bowel disease. EFSA's safety assessment of pasteurized Akkermansia covered adults only, excluding pregnant and lactating women. Anyone on medication for diabetes or other conditions should consult a healthcare professional first.

Akkermansia muciniphila has been studied in relation to obesity, type 2 diabetes, metabolic syndrome and inflammatory bowel disease, where lower levels are commonly reported. Some studies have also observed higher levels in people with Parkinson's disease and multiple sclerosis. These are associations, not proof of cause, and research is ongoing.

You can buy Akkermansia muciniphila in bulk from SwissMedicare Probiotics, a B2B supplier of export-grade freeze-dried powder at 1–100 billion CFU/g, packed in aluminium foil laminated bags, fiber drums or customized export packaging. Supply includes COA, TDS, MSDS, stability studies and regulatory declarations. Use the Enquire button or email probiotic@swissmedicareltd.com.